Jim Cramer spoke with JJ Bienaimé for more on the company's newest drug that treats a very rare disease. » Read More
By: Elizabeth Gurdus
Jim Cramer looks ahead to a tidal wave of earnings and seeks out buying opportunities. » Read More
By: Michelle Fox
Infrastructure stocks have gotten a big boost after President Trump's election, but the run is "not even beginning," Mario Gabelli says. » Read More
By: Fred Imbert
Wall Street has raised its expectations for Amazon and Google's parent company, Alphabet, after they reported great earnings. » Read More
CEO Stack said 2016 was a year of solid execution for the company that set the stage for continued growth of its pain-relief drug, Exparel.
Optimism will spur the market higher this year, but there may be a correction ahead, Wells Capital Management's Jim Paulsen says.
Fiat Chrysler saw its U.S.-listed shares spike more than 6 percent on Friday, boosted by an upgrade at Goldman Sachs.
US District Judge Sue Robinson banned the marketing, selling or manufacturing of Regeneron's cholesterol-lowering drug, Praluent.
For every dollar of IPO proceeds in 2016, $143 was spent on mergers and acquisitions.
The "Fast Money" traders share their first moves for the market open.
Retail stocks have hit the skids, and the move could signal market turmoil ahead, according to some strategists.
RBC says revenue from the company's cable network affiliates will rise to 4 percent in fiscal 2017 from 0.3 percent in fiscal 2016.
A Goldman Sachs analysis of returns since 1999 noted that the January effect has faded compared to a longer history going back to 1974.
The start of the earnings season next week could present an investment opportunity around a group of stocks.
Jim Cramer broke down the performance of the illustrious FANG, and what is behind its recent moves.
Jim Cramer spoke with Halozyme Therapeutics' CEO on its results for phase 2 pancreatic cancer drug.
If December's employment report misses the mark, it wouldn't surprise some of the sourpusses in the bond market.
Jim Cramer says the mall isn't dead yet. The rent is just too darned expensive!
Trump has threatened automakers with a border tax, which he argues will encourage companies to keep production in the U.S., creating jobs for Americans.
Jim Cramer says thanks to the younger generation of shoppers, the Trump rally is out and the FANG rally is back on.
Neither Shopify nor Amazon responded to CNBC's requests for comment about the expected announcement on Thursday.
These are the stocks posting the largest moves after the bell on Thursday, including: Gap, Amgen, Helen of Troy and more.
Trader Jack Ablin sums up the mass destruction retailers are experiencing right now in one neat little chart.
This is the year inflation worries could begin to simmer for the first time in ages.
Get the best of CNBC in your inbox